Acerus Pharmaceuticals Corporation

OTCPK:ASPC.Q Stock Report

Market Cap: US$1.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Acerus Pharmaceuticals Management

Management criteria checks 3/4

Key information

Ed Gudaitis

Chief executive officer

US$807.1k

Total compensation

CEO salary percentage24.7%
CEO tenure4.9yrs
CEO ownership1.0%
Management average tenure3.9yrs
Board average tenure6.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ed Gudaitis's remuneration changed compared to Acerus Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$28m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$807kUS$199k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$664kUS$177k

-US$24m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$190kUS$181k

-US$16m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$19m

Dec 31 2018US$394kUS$185k

-US$19m

Compensation vs Market: Ed's total compensation ($USD807.09K) is about average for companies of similar size in the US market ($USD749.45K).

Compensation vs Earnings: Ed's compensation has increased whilst the company is unprofitable.

CEO

Ed Gudaitis

4.9yrs

Tenure

US$807,086

Compensation

Mr. Edward Gudaitis, also known as Ed, is President, Director and Chief Executive Officer at Acerus Pharmaceuticals Corp. since May 01, 2018. He is a Director for BioteCanada. Mr. Gudaitis has spent many y...

Leadership Team

NamePositionTenureCompensationOwnership
Edward Gudaitis
President4.9yrsUS$807.09k1.03%
$ 17.5k
Gavin Damstra
Senior Vice President of International Commercial3.9yrsUS$411.98kno data
Christopher Sorli
Chief Medical Officer2.8yrsUS$452.01kno data
Naveed Manzoor
Interim Chief Financial Officerless than a yearno datano data
Chris Witty
Investor Relationsno datano datano data
Philippe Savard
Senior VP6.8yrsUS$287.97k0.0046%
$ 78.6

3.9yrs

Average Tenure

Experienced Management: ASPC.Q's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Edward Gudaitis
President4.9yrsUS$807.09k1.03%
$ 17.5k
Samuel Herschkowitz
Vice Chairman1.1yrsno data0.032%
$ 549.6
Ian Ihnatowycz
Chairman of the Board9.6yrsUS$46.15kno data
Stephen Gregory
Independent Director11.8yrsUS$38.12kno data
Borys Chabursky
Lead Independent Director7.3yrsUS$32.11k0.032%
$ 535.9
Geoffrey Cotton
Independent Director2.9yrsUS$44.01kno data

6.1yrs

Average Tenure

69yo

Average Age

Experienced Board: ASPC.Q's board of directors are considered experienced (6.1 years average tenure).